System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Practice Guideline Ppublish 3 citations

PubMed: 39701064 DOI: 10.1159/000543266

International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets.

Horm Res Paediatr 97(6):546-554

Authors: Martin de Bock, Juliana Chizo Agwu, Matt Deabreu, Klemen Dovc, David M Maahs, M Loredana Marcovecchio, Farid H Mahmud, Yeray Nóvoa-Medina, Leena Priyambada, Carmel E Smart, Linda A DiMeglio

Affiliations

  • Department of Paediatrics, University of Otago, Christchurch, New Zealand.
  • Department of Paediatrics, Te Whatu Ora, Waitaha, New Zealand.
  • Department of Paediatrics, Wye Valley NHS Trust, Hereford, UK.
  • Parent and Advocate of Child with Type One Diabetes, Toronto, Ontario, Canada.
  • University Medical Centre Ljubljana, University Children's Hospital, Department of Endocrinology, Diabetes and Metabolic Diseases and University of Ljubljana Faculty of Medicine, Ljubljana, Slovenia.
  • Division of Endocrinology, Department of Pediatrics, Stanford University, Stanford, California, USA.
  • Department of Paediatrics, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Division of Endocrinology, Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • University Institute of Biomedical and Healthcare Research (IUIBS), University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain,.
  • Department of Pediatric Endocrinology, Rainbow Children's Hospital, Hyderabad, India.
  • Paediatric Endocrinology and Diabetes, John Hunter Children's Hospital, Newcastle, New South Wales, Australia.
  • School of Health Sciences, University of Newcastle, Newcastle, New South Wales, Australia.
  • Division of Pediatric Endocrinology and Diabetology, Department of Pediatrics, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Abstract

The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of ≤6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is ≤7.0% (53 mmol/mol). The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of ≤6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is ≤7.0% (53 mmol/mol).

MeSH

Diabetes Mellitus, Child

Cited by